Cargando…
晚期肺鳞癌治疗进展
Lung cancer ranks first both in mobidity and motality in china and worldwild. Squamous cell lung carcinoma is distinguished from lung adenocarcinoma in diagnosis and treatment due to its unique clinical & pathological manifestations and gene mutation characteristics, as a result, it is also expl...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583871/ https://www.ncbi.nlm.nih.gov/pubmed/32798441 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.35 |
Ejemplares similares
-
分子靶向治疗在肺鳞癌中的研究进展
Publicado: (2013) -
肺鳞癌驱动基因研究进展
Publicado: (2014) -
FGFR作为肺鳞癌潜在治疗靶点的研究进展
Publicado: (2018) -
肺鳞癌靶向治疗研究现状
Publicado: (2013) -
晚期肺鳞癌的治疗
Publicado: (2016)